News blog


  • BY: Andrew Hore |
  • POSTED: 10/06/2014 |

Infection control products supplier Tristel has issued a positive trading statement that has led to the fourth forecast upgrade in 2014.

The 2013-14 forecast has been raised from 1.5m to 1.8m, up from 475,000 in 2012-13, thanks to higher gross margins. That figures was the original forecast for the year to June 2015 and this has been raised to 2.3m.

The expectation for the dividend has been raised from 1.4p a share to 1.6p a share.

Sales are growing in each of the three divisions - human healthcare, animal healthcare and contamination control. Costs are stable so the improved margins are having a significant effect on profit.

At 75.5p a share, up 11p, Tristel is valued at 30.8m. The shares are trading on 24 times 2013-14 prospective earnings, falling to 18 in 2014-15. 

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds